BNNC
BNNC is a Photomolecular glue. BNNC selectively releases (R)-CR8 (HY-18340) (a Cyclin K molecular glue) and BSS-Et in hypoxic tumor microenvironments, thereby triggering Cyclin K degradation dependent on the ubiquitin-proteasome pathway. BNNC generates ROS and singlet oxygen in hypoxic tumor cells under light irradiation. BNNC enhances DNA damage and Apoptosis through the combined effects of Cyclin K degradation and phototherapy. BNNC enhances the tumor selectivity of molecular glue via specific activation in hypoxic tumor microenvironments. BNNC can be used in breast cancer-related research.
For research use only. We do not sell to patients.
- Formula: C72H70ClN13O6
- Molecular Weight:1248.86
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Description
In Vitro
BNNC (300 μg/mL RLM, 100 μM NADH; 40 min) exhibits stable and robust phototherapeutic functions and stability; after incubation with 300 μg/mL RLM for 40 min, it can fully respond to hypoxic environments to release (R)-CR8 and BSS-Et[1].
BNNC (30 μM; 1.5 h) generates reactive oxygen species in hypoxic 4T1 cells after 5 min of irradiation with an 808 nm laser at a power density of 1.5 W·cm−2[1].
BNNC (30 μM; 2 h) selectively induces ubiquitin-proteasome-dependent Cyclin K degradation in hypoxic 4T1 cells, but exerts no such effect in normoxic 4T1 cells[1].
BNNC (0-30 μM; 24 h) exhibits enhanced synergistic cytotoxicity against hypoxic 4T1 cells under 808 nm laser irradiation, reducing cell viability to less than 20% at a concentration of 30 μM, whereas it shows low cytotoxicity toward L02 hepatocytes at the same concentration[1].
BNNC (0-30 μM) induces extensive 4T1 cell death under hypoxic conditions combined with 808 nm laser irradiation, and the proportion of dead cells is much higher than that of either single treatment[1].
BNNC (30 μM; 2 h) significantly increases the level of activated Caspase-3 in hypoxic 4T1 cells upon irradiation with an 808 nm laser[1].
BNNC (10-100 μM; 3 h) exhibits excellent hemocompatibility in mouse red blood cells, with a hemolysis rate of less than 5% even at a concentration of 100 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Mouse breast cancer 4T1 cells
-
Concentration:30 μM
-
Incubation Time:2 h
-
Result:Caused no change in Cyclin K protein levels under normoxic (21% O2) conditions.
Induced a marked reduction in Cyclin K protein levels under hypoxic (2% O2) conditions, comparable to free (R)-CR8.
Showed reversed Cyclin K degradation when pretreated with proteasome inhibitor MG132.
-
Cell Line:Mouse breast cancer 4T1 cells, human hepatocyte L02 cells
-
Concentration:0-30 μM
-
Incubation Time:24 h total; 2 h drug incubation prior to 5 min 808 nm laser irradiation
-
Result:Maintained >80% cell viability across all concentrations in normoxic (21% O2) dark conditions.
Showed concentration-dependent cytotoxicity comparable to BSS-Et under normoxic conditions with irradiation.
Exhibited enhanced concentration-dependent cytotoxicity in hypoxic (2% O2) dark conditions, similar to (R)-CR8.
Reduced hypoxic 4T1 cell viability to below 20% at 30 μM under irradiation.
Preserved >80% viability in L02 cells at 30 μM.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (female, 7-8 weeks old, subcutaneous 4T1 breast cancer xenograft model)[1]
-
Dosage:30 μM (with 808 nm laser irradiation); 30 μM (without irradiation)
-
Administration:intratumorally; every other day; 21 days (7 cycles); 808 nm laser irradiation (1.5 W·cm-2, 10 min, 2 hours post each injection) for laser group
-
Result:Delayed tumor growth similarly to (R)-CR8 without irradiation.
Induced tumor growth arrest starting at day 12, culminating in overt tumor ablation with laser irradiation, with significantly greater efficacy than BSS-Et with laser irradiation, (R)-CR8, or BNNC without laser.
Marked Cyclin K depletion in BNNC-treated tumors confirmed via Western blot.
Showed greater γ-H2AX (DNA damage marker) levels in BNNC + laser tumors compared to single-agent groups.
Revealed minimal proliferative activity in BNNC + laser tumors via Ki67 immunohistochemistry.
Confirmed the most extensive apoptotic manifestations in BNNC + laser group via TUNEL and H&E staining.
Caused no appreciable body-weight loss.
Showed no morphological abnormalities, inflammatory infiltrates, or necrotic lesions in major organs (heart, liver, spleen, lung, kidney) via histopathological examination.
Chemical Information
-
Molecular Weight 1248.86
-
Formula C72H70ClN13O6
-
SMILES
CC[C@H](COC(OCC(C=C1)=CC=C1/N=N/C(C=C2)=CC=C2COC(C(C=C3)=CC4=C3N(CC)/C(C4(C)C)=C\C=C5CCCC(/C=C/C(C(C)(C)O/6)=C(C#N)C6=C(C#N)\C#N)=C/5Cl)=O)=O)NC7=NC(N(C(C)C)C=N8)=C8C(NCC(C=C9)=CC=C9C%10=NC=CC=C%10)=N7
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)